213 related articles for article (PubMed ID: 26311783)
1. Oncostatin M Confers Neuroprotection against Ischemic Stroke.
Guo S; Li ZZ; Gong J; Xiang M; Zhang P; Zhao GN; Li M; Zheng A; Zhu X; Lei H; Minoru T; Li H
J Neurosci; 2015 Aug; 35(34):12047-62. PubMed ID: 26311783
[TBL] [Abstract][Full Text] [Related]
2. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.
Larrea E; Echeverria I; Riezu-Boj JI; Aldabe R; Guembe L; Sola I; Civeira MP; Sarobe P; Prieto J
J Hepatol; 2014 Mar; 60(3):482-9. PubMed ID: 24418171
[TBL] [Abstract][Full Text] [Related]
5. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.
Hermans D; Houben E; Baeten P; Slaets H; Janssens K; Hoeks C; Hosseinkhani B; Duran G; Bormans S; Gowing E; Hoornaert C; Beckers L; Fung WK; Schroten H; Ishikawa H; Fraussen J; Thoelen R; de Vries HE; Kooij G; Zandee S; Prat A; Hellings N; Broux B
Acta Neuropathol; 2022 Aug; 144(2):259-281. PubMed ID: 35666306
[TBL] [Abstract][Full Text] [Related]
7. The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis.
Marden G; Wan Q; Wilks J; Nevin K; Feeney M; Wisniacki N; Trojanowski M; Bujor A; Stawski L; Trojanowska M
Arthritis Res Ther; 2020 Jul; 22(1):179. PubMed ID: 32736577
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
10. Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice.
Yamashita S; Komori T; Kohjimoto Y; Miyajima A; Hara I; Morikawa Y
Sci Rep; 2020 Oct; 10(1):17150. PubMed ID: 33051515
[TBL] [Abstract][Full Text] [Related]
11. Loss of oncostatin M receptor beta in metastatic melanoma cells.
Lacreusette A; Nguyen JM; Pandolfino MC; Khammari A; Dreno B; Jacques Y; Godard A; Blanchard F
Oncogene; 2007 Feb; 26(6):881-92. PubMed ID: 16909117
[TBL] [Abstract][Full Text] [Related]
12. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns.
Bando T; Morikawa Y; Komori T; Senba E
Neuroscience; 2006 Nov; 142(4):1263-71. PubMed ID: 16926070
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.
Takata F; Dohgu S; Sakaguchi S; Sakai K; Yamanaka G; Iwao T; Matsumoto J; Kimura I; Sezaki Y; Tanaka Y; Yamauchi A; Kataoka Y
Neuroscience; 2019 Dec; 422():12-20. PubMed ID: 31705893
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms.
Blanchard F; Wang Y; Kinzie E; Duplomb L; Godard A; Baumann H
J Biol Chem; 2001 Dec; 276(50):47038-45. PubMed ID: 11602599
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
Komori T; Morikawa Y
Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
Luo P; Wang PX; Li ZZ; Zhang XJ; Jiang X; Gong J; Qin JJ; Guo J; Zhu X; Yang S; Li H
Am J Pathol; 2016 May; 186(5):1278-92. PubMed ID: 26976243
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori outer membrane vesicles induce expression and secretion of oncostatin M in AGS gastric cancer cells.
Zoaiter M; Nasser R; Hage-Sleiman R; Abdel-Sater F; Badran B; Zeaiter Z
Braz J Microbiol; 2021 Sep; 52(3):1057-1066. PubMed ID: 33851342
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
[TBL] [Abstract][Full Text] [Related]
20. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
